Hat tip to hay flick YMB

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply

biopearl123
Posts: 268
Joined: Fri Jul 20, 2018 5:13 pm

Re: Hat tip to hay flick YMB

Post by biopearl123 » Sun Feb 09, 2020 7:47 pm

Worth a read in light of the WIPO post:

https://www.nature.com/articles/leu2013 ... rigin=ppub

Ryan
Posts: 62
Joined: Sat Jul 08, 2017 1:41 pm

Re: Hat tip to hay flick YMB

Post by Ryan » Sun Feb 09, 2020 9:33 pm

Still all about the trial(s), but this is interesting. Thanks to hay flick, even the name delivers knowledge, but there is no “limit” to the knowledge and latest news he’s delivering. (It’s a nerd joke.)

biopearl123
Posts: 268
Joined: Fri Jul 20, 2018 5:13 pm

Re: Hat tip to hay flick YMB

Post by biopearl123 » Mon Feb 10, 2020 2:15 am

Ryan, I think you were the one who said Geron was screening on the basis of molecular signature and I took issue since there was no mention on the clinical trials site. Looks like you will tun out to be right for future use!! I hope so. Regards, bp

cheng_ho
Posts: 119
Joined: Sun Apr 03, 2016 11:27 pm

Re: Hat tip to hay flick YMB

Post by cheng_ho » Mon Feb 10, 2020 4:01 pm

No, you were right, biopearl. Geron isn't doing genetic screening in the trials... and so far they've recruited only half the patients they need for the MDS trial, even just taking whatever victims Paraxel can find.

This is just a hope for the future. Maybe in a Phase 3 design for MF?

Post Reply